UCB SA (UCBJF)

Sage Therapeutics Revenue

UCB SA had revenue of 3.36B EUR in the half year ending December 31, 2024. This brings the company's revenue in the last twelve months to 6.85B, up 25.56% year-over-year. In the year 2024, UCB SA had annual revenue of 6.15B with 18.72% growth.

• Revenue (ttm): 6.85B EUR
• Revenue Growth: +25.56%
• P/S Ratio: 5.04
• Revenue / Employee: 730.22K EUR
• Employees: 9,378
• Market Cap: 40.55B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	6.15B	970.00M	18.72%
Dec 31, 2023	5.18B	-265.00M	-4.87%
Dec 31, 2022	5.45B	-330.00M	-5.71%
Dec 31, 2021	5.78B	430.00M	8.04%
Dec 31, 2020	5.35B	434.00M	8.83%